Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.
Grinshpun A, Russo D, Ma W, Verma A, Hermida-Prado F, Sherman S, Gaglia G, Kabraji S, Kirkner G, Hughes ME, Lin NU, Sandusky Z, Nardone A, Guarducci C, Nguyen QD, Santagata S, Nagy Z, Jeselsohn R.
Grinshpun A, et al. Among authors: nguyen qd.
NPJ Breast Cancer. 2024 Jun 8;10(1):42. doi: 10.1038/s41523-024-00647-1.
NPJ Breast Cancer. 2024.
PMID: 38851818
Free PMC article.